fda approval in cll and fl, partial hold lifted in tazmetostat trials, and more
Published 5 years ago • 161 plays • Length 11:13
Download video MP4
Download video MP3
Similar videos
-
11:34
fda approval in cll, recommendation in sts, partial hold on cervical cancer trial, and more
-
7:26
fda approval in ovarian cancer, priority reviews in nsclc, cll, and follicular lymphoma, and more
-
13:36
fda approval in prostate cancer, nda submitted in cll and follicular lymphoma, and more
-
5:21
fda approvals in cll and all, nda accepted in melanoma, and more
-
9:46
fda approval in cll, recommendation in nsclc, missed endpoint in gbm study, and more
-
8:49
fda approvals in cml, ctcl, cmv infection, and tumor assay, and clinical holds lifted
-
9:41
fda approvals in follicular lymphoma and prostate cancer, biosimilar is granted approval, and more
-
24:22
highlight of cll-related 2016 fda approvals: venetoclax
-
3:41
future of pi3k inhibition in fl and cll
-
1:06
dr. flinn on the fda approval of duvelisib in cll and follicular lymphoma
-
9:35
fda approvals in breast cancer and of a biosimilar, nda submitted in cll, and more
-
1:16
dr. leonard on the fda approval of tazemetostat in follicular lymphoma
-
0:33
onclive news network preview: fda approval in head and neck cancer
-
10:46
fda approval in all, priority reviews in cml and breast cancer, and more
-
9:10
fda approvals in cml and hodgkin lymphoma, priority review in crc, and more
-
8:10
fda approval for cll, odac vote in lung cancer, european regulatory advances, and more
-
0:31
preview: fda approvals in cll and all, nda accepted in melanoma, and more
-
1:01:48
update on oral therapies in lymphoma and cll | lrf webinars
-
7:11
review on 2016 fda approvals, halt on aml trials, and more
Clip.africa.com - Privacy-policy